SH2B1 Deficiency Obesity

Clinical trial pipeline · Data from ClinicalTrials.gov

See which SH2B1 Deficiency Obesity trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

CompletedPhase 2

NCT03013543

Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity

The purpose of the study was to determine the effect of setmelanotide (RM-493) on weight, hunger assessments, and other factors in participants with rare geneti…

United States213 participantsStarted 2017-02-10

Treatment: Setmelanotide

UnknownPhase 2

NCT05532020

An Open-Label Study of Diazoxide Choline in Patients With Genetic Obesities

This is a phase 2 open-label, one-arm, clinical study to evaluate the efficacy and safety of DCCR (diazoxide choline) extended-release tablets over 1 year of tr…

Location not specified30 participantsStarted 2023-01

Treatment: DCCR (diazoxide choline) extended-release tablets